Clinical Trials Directory

Trials / Completed

CompletedNCT00927979

Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy

Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Carmel Medical Center · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

Detailed description

Outcome Measures : * VAS score * Use of analgesics during operation and postoperative period

Conditions

Interventions

TypeNameDescription
DRUG10 mLRopivacaine 1%Intraperitoneal nebulization of 10 mL Ropivacaine 1%
DRUGWater for injectionIntraperitoneal nebulization of 10 mL water for injection
DRUG10 mL Ropivacaine 1%Intraperitoneal nebulization of 10 mL Ropivacaine 1%

Timeline

Start date
2009-06-01
Primary completion
2010-07-01
Completion
2010-10-01
First posted
2009-06-25
Last updated
2011-06-28

Source: ClinicalTrials.gov record NCT00927979. Inclusion in this directory is not an endorsement.